Registry for patients undergoing percutaneous transluminal angioplasty
PTA Registry - an Observational Study of Percutaneous Transluminal Angioplasty
This study collects information from patients who are having a minimally invasive procedure called angioplasty to see how well it works and how safe it is for different people with peripheral artery disease.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Heinrich-Heine University, Duesseldorf Academic / other |
| Locations | 1 site (Düsseldorf) |
| Trial ID | NCT02728479 on ClinicalTrials.gov |
What this trial studies
This registry collects clinical data from patients who are undergoing percutaneous transluminal angioplasty (PTA), a minimally invasive procedure used to treat peripheral artery disease. The study is observational and aims to systematically assess the characteristics and outcomes of these patients. By gathering this data, researchers hope to better understand the effectiveness and safety of PTA in various patient populations.
Who should consider this trial
Good fit: Ideal candidates for this registry are patients who are scheduled to undergo percutaneous transluminal angioplasty.
Not a fit: Patients under 18 years old will not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could provide valuable insights that improve treatment strategies for patients with peripheral artery disease.
How similar studies have performed: While this registry approach is common in clinical research, the specific outcomes of PTA have been previously studied, indicating potential for valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients undergoing PTA Exclusion Criteria: * \< 18 years
Where this trial is running
Düsseldorf
- Division of Cardiology, Pulmonary Disease and Vascular Medicine — Düsseldorf, Germany (Recruiting)
Study contacts
- Principal investigator: Christian Heiss, MD — Division of Cardiology, Pulmonary Disease and Vascular Medicine
- Study coordinator: Christian Heiss, MD
- Email: christian.heiss@med.uni-duesseldorf.de
- Phone: +49 211 8118800
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.